A randomized controlled clinical trial to examine effects of intranasal dexmedetomidine, an
α2-adrenorecptor agonist, on pain control and agitation in children undergoing BMT.
Phase:
Phase 4
Details
Lead Sponsor:
Children's National Research Institute Children's Research Institute
Collaborators:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer